THC/CBD Rat Brain Imaging: Why Dose and Anesthesia Limit ‘Protection’ Claims

forensic toxicology working group members October 28, 2026 Forensic Toxicology

A rat imaging study found distinct THC, CBD and combination patterns in connectivity and blood flow. The mixture moderated some THC-associated findings, but the experiment does not establish a human protective ratio or a validated impairment test.

The exposures were not identical across arms

Adult male rats received injected THC, CBD, their mixture or vehicle before functional imaging. THC alone was 10 mg/kg, CBD alone was 150 mg/kg, and the mixture contained approximately 10.8 mg/kg THC with 10 mg/kg CBD.

The CBD dose in the single-compound arm was therefore much larger than the CBD dose in the mixture. Comparing those patterns is informative, but it is not a same-dose factorial test of every component effect.

Connectivity and perfusion are different measures

THC increased selected connectivity metrics and cerebral blood flow. CBD reduced connectivity metrics without a significant blood-flow effect. The combination showed moderated changes relative to THC alone.

BOLD connectivity describes relationships between imaging signals. It does not directly record cognition, and a change in perfusion cannot be automatically called either benefit or harm. The study examined healthy animals rather than a disease model.

Anesthesia belongs in the interpretation

Imaging was performed in anesthetized rats. Anesthetic effects and possible drug interactions can influence both connectivity and circulation; the authors identified this as a limitation. Only males were studied, and some scans were excluded for image quality.

Several authors had pharmaceutical-industry affiliations. That context accompanies the design when considering therapeutic extrapolations.

These results support mechanistic investigation. They cannot show that adding CBD restores human driving ability, removes all THC effects or produces the same response during awake, ordinary cannabis use.